<DOC>
	<DOCNO>NCT01086904</DOCNO>
	<brief_summary>The study aim assess safety efficacy inactivate non adjuvanted Influenza A ( H1N1 ) vaccine renal transplant recipient .</brief_summary>
	<brief_title>Safety Efficacy Inactivated Non Adjuvanted Vaccine Against Influenza A Renal Transplant Recipients</brief_title>
	<detailed_description>120 renal transplant recipient triple immunosuppression immunize influenza H1N1v . The primary endpoint humoral immunity assess 21 day injection day 0 day 21 : - seroprotection rate , define percentage patient antibody title Hemaglutinin ≥ 1/40e immunization - seroconversion rate , define percentage patient antibody title Hemaglutinin &lt; 1/10e immunization ≥ 1/40e prevaccine title ≥1/10e increase least 4 fold immunization - seroconversion factor , define ratio pre post vaccine geometrical mean antibody title . Secondary endpoint : - Seroconversion rate , seroprotection rate seroconversion factor day 182 - Percentage patient antibody title &gt; 1/40e day 182 ( Immune memory ) - Number severity clinical biological adverse event - Number case pandemic H1N1v influenza virologically confirm - Study associate parameter influence result H1N1v vaccination term seroprotection , seroconversion seroconversion factor - Assessment cellular immune response H1N1v - Assessment H1N1v vaccination graft function humoral anti-HLA response .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : Age &gt; 18 &lt; 60 year old Signed information consent Social security coverage Renal transplantation &gt; 6 month creatinine clearance &gt; 20 ml/mn Stable renal function define serum creatinine variation &lt; 20 % last three month Receiving triple immunosuppression regimen include steroid , Calcineurine inhibitor ( cyclosporine Tacrolimus ) , IMPDH inhibitor ( Mycophenolate Mofetil mycophenolic acid ) Regular followup For child bear age female : Negative urinary HCG Contraception first three month study Exclusion criterion : Poor renal function define creatinine clairance &lt; 20 ml/mn Unstable renal function define serum creatinine variation &gt; 20 % last 3 month Cellular humoral acute rejection episode last 3 month inclusion Known HIV , HBV HCV infection Other vaccine administer last 3 week inclusion schedule month second vaccine injection Known allergy egg proteins one vaccine compound Severe adverse event prior administration influenza vaccine Multiple sclerosis Past history Guillain Barre syndrome Fever inclusion H1N1 influenza episode positive virological test last 6 month Contact people infect H1N1 influenza week prior inclusion Cancer require radiotherapy chemotherapy last 6 month Blood transfusion last 3 month Pregnancy last 3 month No followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>renal transplantation</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>inflenza A ( H1N1 )</keyword>
	<keyword>vaccine</keyword>
</DOC>